These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 15604097

  • 1. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).
    Lepourcelet M, Tou L, Cai L, Sawada J, Lazar AJ, Glickman JN, Williamson JA, Everett AD, Redston M, Fox EA, Nakatani Y, Shivdasani RA.
    Development; 2005 Jan; 132(2):415-27. PubMed ID: 15604097
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activity.
    Abouzied MM, Baader SL, Dietz F, Kappler J, Gieselmann V, Franken S.
    Biochem J; 2004 Feb 15; 378(Pt 1):169-76. PubMed ID: 14572309
    [Abstract] [Full Text] [Related]

  • 6. Identification of differentially expressed genes in oral squamous cell carcinoma.
    Arora S, Matta A, Shukla NK, Deo SV, Ralhan R.
    Mol Carcinog; 2005 Feb 15; 42(2):97-108. PubMed ID: 15599930
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Overlapping gene expression in fetal mouse intestine development and human colorectal cancer.
    Hu M, Shivdasani RA.
    Cancer Res; 2005 Oct 01; 65(19):8715-22. PubMed ID: 16204040
    [Abstract] [Full Text] [Related]

  • 9. Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation.
    Enomoto H, Yoshida K, Kishima Y, Kinoshita T, Yamamoto M, Everett AD, Miyajima A, Nakamura H.
    Hepatology; 2002 Dec 01; 36(6):1519-27. PubMed ID: 12447878
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM, Brown KR, Shih W, Wigle DA, Radulovich N, Jurisica I, Tsao MS.
    Oncogene; 2006 Jan 05; 25(1):91-102. PubMed ID: 16158056
    [Abstract] [Full Text] [Related]

  • 12. Phases of canonical Wnt signaling during the development of mouse intestinal epithelium.
    Kim BM, Mao J, Taketo MM, Shivdasani RA.
    Gastroenterology; 2007 Aug 05; 133(2):529-38. PubMed ID: 17681174
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of gene expression profile in colon cancer using the Cancer Genome Anatomy Project and RNA interference.
    Huang ZG, Ran ZH, Lu W, Xiao SD.
    Chin J Dig Dis; 2006 Aug 05; 7(2):97-102. PubMed ID: 16643337
    [Abstract] [Full Text] [Related]

  • 16. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
    Yoshida K, Tomita Y, Okuda Y, Yamamoto S, Enomoto H, Uyama H, Ito H, Hoshida Y, Aozasa K, Nagano H, Sakon M, Kawase I, Monden M, Nakamura H.
    Ann Surg Oncol; 2006 Feb 05; 13(2):159-67. PubMed ID: 16411141
    [Abstract] [Full Text] [Related]

  • 17. The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer.
    Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G, Emmert-Buck MR, Petricoin EF, Krizman DB, Liotta LA, Kohn EC.
    Clin Cancer Res; 2003 Jan 05; 9(1):44-51. PubMed ID: 12538450
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knüchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG.
    Oncogene; 2007 Aug 16; 26(38):5680-91. PubMed ID: 17353908
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.